Stay updated on 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.

Latest updates to the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedDifference0.2%

- Check11 days agoChange DetectedAdded a new MedlinePlus Genetics topic on multiple myeloma to broaden educational coverage.SummaryDifference0.3%

- Check18 days agoChange DetectedRemoved a MedlinePlus Genetics topic on multiple myeloma, reducing core content and a related proper noun topic.SummaryDifference0.3%

- Check25 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference5%

- Check32 days agoChange DetectedUpdated disease terminology to Multiple myeloma and bumped to revision v3.1.0, replacing Plasma cell myeloma, Therapeutics, Phlebotomy, and removing v3.0.2.SummaryDifference0.8%

- Check39 days agoChange Detected- Added MedlinePlus Genetics topic: Multiple myeloma. - No deletions; overall page content expands to include genetic information on this condition.SummaryDifference0.4%

Stay in the know with updates to 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.